Results 21 to 30 of about 7,271,878 (304)

Equity and capacity to benefit from early access to medicines schemes

open access: yesInternational Journal for Equity in Health
Many diseases, especially rare ones, have not gained the attention or support needed to attract dedicated research interest to be able to develop successful medicines.
Sarah J. L. Edwards   +4 more
doaj   +1 more source

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Whose Responsibility Is It? Implementing Patient-Prioritized Healthcare System Change in Oncology

open access: yesCurrent Oncology
This brief commentary describes the reflections on a fundamental question by the Public Interest Group on Cancer Research, a successful academic-community partnership focused on cancer research, education, public engagement, and advocacy in Canada’s ...
Holly Etchegary, John King, Sevtap Savas
doaj   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Weighing the Public Interest [PDF]

open access: yes, 2006
In 1981, the AICPA addressed the issue of going concern status through SAS 34, The Auditor\u27s Considerations When a Question Arises About an Entity\u27s Continued Existence.
Akers, Michael   +2 more
core   +1 more source

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski   +9 more
wiley   +1 more source

In the Public Interest [PDF]

open access: yesMAB, 2017
The 2nd International FAR Conference on June 7 and 8 focused on the topic ‘Controversies in Future Audit Quality – A multi-stakeholder perspective'.
Philip Wallage
doaj   +3 more sources

US state variations in food bank donation policy and implications for nutrition

open access: yesPreventive Medicine Reports, 2022
Food insecurity has increased dramatically in 2020 as a result of the COVID-19 public health and economic crisis. Many more families in the United States are turning to the charitable food system to help meet their needs.
Katelin M. Hudak   +3 more
doaj   +1 more source

Constitutional Remedies & Public Interest Balancing [PDF]

open access: yes, 2013
The conventional account of our remedial tradition recognizes that courts may engage in discretionary public interest balancing to withhold the specific remedies typically administered in equity.
Greabe, John M.
core   +2 more sources

Home - About - Disclaimer - Privacy